IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma. [electronic resource]
Producer: 20180416Description: 27012 p. digitalISSN:- 2045-2322
- Adolescent
- Antineoplastic Agents -- pharmacology
- Biomarkers, Tumor -- antagonists & inhibitors
- Case-Control Studies
- Cell Adhesion
- Cell Line, Tumor
- Cell Movement
- Cell Proliferation
- Cerebellar Neoplasms -- cerebrospinal fluid
- Child
- Drug Screening Assays, Antitumor
- Female
- Gene Expression
- Humans
- Inhibitory Concentration 50
- Insulin-Like Growth Factor Binding Protein 3 -- cerebrospinal fluid
- Insulin-Like Growth Factor I -- cerebrospinal fluid
- Male
- Matrix Metalloproteinase 9 -- cerebrospinal fluid
- Medulloblastoma -- cerebrospinal fluid
- Meningeal Neoplasms -- cerebrospinal fluid
- Molecular Targeted Therapy
- Plasminogen Activator Inhibitor 1 -- cerebrospinal fluid
- Receptor, IGF Type 1
- Receptors, Somatomedin -- antagonists & inhibitors
- Tissue Inhibitor of Metalloproteinase-1 -- cerebrospinal fluid
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.